- An end to manufacturer rebates as we know them today?
By Deana Bell, Jennifer Carioto, Matthew Hayes | 15 February 2019
The proposed rule to make drug manufacturer rebates no longer protected under the Anti-Kickback Statute has broad impacts to federally funded prescription drug programs, especially Medicare Part D.
- Year-End 2018 Actuarial Function: What's new
By Aisling Barrett, Eoin King | 15 February 2019
This briefing note highlights what’s new for actuarial functions in Ireland to consider at year-end 2018.
- Recommendations for developing a Stress and Scenario Testing framework
By Emma Hutchinson, Fred Vosvenieks | 15 February 2019
This note provides high-level recommendations for insurance companies when developing or enhancing their Stress and Scenario Testing framework.
- Pathways to Success MSSP final rule: Winners and losers
By Anders Larson, Cory Gusland | 14 February 2019
This paper examines the Medicare Shared Savings Program’s (MSSP) final rule from the perspective of different accountable care organization (ACO) situations to help readers understand how the MSSP rule might affect different ACOs.
- Public Pension Funding Index, 4th Quarter 2018
By Rebecca A. Sielman | 14 February 2019
The estimated funded status of the 100 largest U.S. public pension plans dropped from 72.9% at the end of September to 67.2% at the end of December as measured by the Milliman 100 Public Pension Funding Index (PPFI).
- Giving nonqualified deferred compensation plans their due diligence in M&As: Part II - Top-hat and FICA fitness
By Henrik P. Patel, Dominick Pizzano | 14 February 2019
Will the nonqualified deferred compensation plans (NDCPs) still fit within the top-hat exemption post-merger and have the NDCPs Federal Insurance Contributions Act taxes been properly applied to the benefits?
- Milliman Market Monitor London - 31 January 2019
By Neil Dissanayake, Peter Lin | 13 February 2019
European equity markets made strong gains in January, fully recovering from the slump in December, on the back of improving relationships between China and the US and signs of the Federal Reserve being more patient on raising interest rates.
- Student loans and regulation: A bumpy ride for borrowers
By Leighton A. Hunley, Katherine A. Pipkorn | 13 February 2019
Student loans now account for 10.7% of overall household debt, though a decade ago they accounted for less than 5%.
- Milliman VALUES 2018 GLWB industry lapse study
By Eileen S. Burns, Matthias Kullowatz, Jenny Jin, Ben Johnson, Vincent Haupt, Vincent Embser | 13 February 2019
The 2018 Milliman VALUES Guaranteed Lifetime Withdrawal Benefit (GLWB) industry lapse and utilization studies included 3 million policyholders from eight large variable annuity writers, representing roughly $350 billion of account value and covering a range of GLWB product designs as well as demographic attributes.
- LTSS services in Medicare Advantage Plans
By Pedro Alcocer, Robert Eaton, Pamela Laboy | 12 February 2019
This article addresses how the Medicare Advantage marketplace responded in 2019 to the Centers for Medicare and Medicaid Services’s expanded definition of primarily health-related benefits, including which supplemental benefits plans are offering and where these benefits are offered.